Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexium for prevention of NSAID-associated gastric ulcers
NCT00629512Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2001
- Primary completion
- Dec 2002
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of esomeprazole in gastric ulcer and duodenal ulcer (3 arms), sponsored by AstraZeneca. Primary endpoint: Incidence of gastric and/or duodenal ulcers at 6 months. Started Mar 2001; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT00629512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629512.